TAK vs VTRS
Takeda Pharmaceutical Company Limited · Viatris Inc.
Relative return (rebased to 100)
Key stats
| Metric | TAK | VTRS |
|---|---|---|
| Price | $21.77 | $19.63 |
| Market Cap | $34.63B | $22.50B |
| P/E | — | — |
| P/B | — | 1.64 |
| P/S | — | 1.57 |
| ROE | — | -25.7% |
| Net Margin | — | -24.6% |
| Gross Margin | — | 35.1% |
| Revenue Growth | — | -3.0% |
| Dividend Yield | — | 2.45% |
| EPS | — | -$3.07 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.